Absorption Pharmacokinetics

Absorption Pharmacokinetics

Conflicts of Interest Top 10 Prescribed Medications . Pharmaceutical Company Speakers Bureau: in Pediatrics None . Pharmaceutical Consulting: None . Medical Device or Lab Consulting: None Anthony J. Busti, MD, PharmD, BSN, FNLA, FAHA . Stock or Financial Interests in Pharmaceutical Faculty, High‐Yield MED Reviews and Medical Device Companies: None Editor‐in‐Chief, Pharmacology Weekly San Antonio, TX . Drug Company Funded Research: None Emergency Medicine Residency Program Johns Hopkins Hospital Baltimore, MD 2 Pediatrics: Absorption . Oral: The Pediatric Patient – Gastric fluids are essentially neutral in the first hrs of life; by the 2nd yr of life gastric output is equal to adult Pharmacokinetics & Pharmacodynamics on per kg basis. – pH‐dependent passive diffusion • full‐term infant: declines from 6‐8 at birth, 1‐3 after 24 hours – Gastric‐emptying time • Not significantly slower, though may not reach adult times until 6‐8 months. 3 4 Pharmacokinetics Pharmacokinetics: Clearance Pathways . First Pass Metabolism: NAT – Clinical Application: Esterase FMO • Lidocaine vs. mexiletine (Mexitil) MAO • Propranolol (Inderal) • Meperidine (Demerol) UGT ≈ 35% CYP450 – Influenced by: • Influx & efflux transporters • Phase I (CYP450) mediated metabolism • Phase II mediated metabolism FMO = flavin monooxygenase MAO = monoamine oxidase NAT = n-acetyltransferase UGT = Uridine glucuronosyltransferase 6 5 Williams J et al. Drug Metab Disp 2004;32:1201-08. NOTE: NOT ALL drugs require transporters to get across cell membranes! Some will make it across by diffusion depending on the charge and degree NOTE: NOT ALL drugs require transporters to get across cell membranes! Some will make it across by diffusion depending on of lipophilicity. 7 the charge and degree of lipophilicity. 8 Pediatrics: Distribution Pharmacokinetics . Distribution: . Volume of distribution: – To understand where drug can be and is measured, one – Influence on hydrophilic & lipophilic needs to have a basic understanding of the various “fluid – Ex. Aminoglycosides: are hydrophilic and distribute more into extracellular space so more needed to achieve plasma compartments” in the body where drug can reside. levels. Total Body Water (60% of body weight; 70kg = 42 L) . Plasma protein binding: Intracellular Extracellular (40% or 2/3 of body weight; 28 L) (20% or 1/3 of body weight; 14 L) – In neonates, albumin 80% of an adult and ‐1 acid (mainly K+, Mg+) (mainly Na+, Cl‐, HCO‐_ glycoprotein also less than adult – Bilirubin can compete with binding sites on albumin with Plasma Interstitial other meds. (5% or 1/4 of body weight; 3L) (15% or 3/4 of body weight; 10 L) (mainly protein) (No protein) 9 10 Pharmacokinetics Pharmacokinetics . Phase I Metabolism: . Phase I Metabolism: – Oxidation / Reduction via primarily the CYP450 – Oxidation / Reduction via primarily the CYP450 enzyme system. enzyme system. • Found in the liver (mainly), intestine, lungs and kidneys. • The major groups in drug metabolism & drug interactions • Purpose is for microsomal (CYP450) enzymes to give/add a include 1,2,3, and 4; they are then further divided into functional group to the drug molecule in preparation for groups by chemical structure A,B,& C. These are then sub‐ phase II metabolism and/or elimination. Those functional divided into sub‐groups 1,2,3, etc… groups are: • Most common: CYP 1A2, 2C9, 2C19, 2D6, 3A4 – COOH – CYP2B6 (3% of meds) – OH – CYP2E1 (4% of meds) – NH2 – CYP2C19 (8% of meds) – SH – CYP1A2 (11% of meds) • Metabolite can be active or inactive – CYP2C9 (16% of meds) • Require presence of NADPH, O2 to function – CYP2D6 (19% of meds) – CYP3A4 (36% of meds) 11 12 Pharmacokinetics Pharmacokinetics . Phase II Metabolism: . Phase I Metabolism: – Conjugation reactions carried out by mainly – Oxidation / Reduction via primarily the CYP450 nonmicrosomal enzymes that add a compound to the enzyme system. drug to increase hydrophilicity (these compounds to be highly polar or ionized). Almost always inactive • Subject to induction and inhibition metabolites. • Are subject to genetic polymorphisms. • Glucuronidation (e.g., via UDP‐glucuronosyltransferases; – Examples: 2C9 (warfarin), 2C19 (clobazam; clopidogrel), 2D6 UGT1A1) (tamoxifen; psych meds; beta‐blockers) – Most common one – Only one in Phase II metabolism that is microsomal enzyme as CYP450 • Sulfation: sulfotransferases (SULT) • Acetylation: N‐acetyltransferase (NAT) • Glutathione conjugation (e.g. for acetaminophen) • Methylation – methyltransferase (MT) 13 14 Pharmacokinetics: UGT Enzymes Pediatrics: Elimination UGT1A6 UGT1A3 UGT1A6 . Glomerular filtration, tubular secretion, tubular UGT1A10 UGT2B7 reabsorption may take several weeks to 1 year UGT1A8 to develop fully . Results in decreased dose requirement UGT1A4 UGT1A1 15 Williams J et al. Drug Metab Disp 2004;32:1201-08. 16 17 18 Factors Affecting Therapy Pharmacokinetics . Creatinine Clearance: Zero‐order Kinetics (Elimination) 1st‐order Kinetics (Elimination) Rate of drug elimination per hour is Rate of drug elimination per hour is – Schwartz Method: CLcr = K x L/Scr “independent” of drug concentration (i.e. “dependent” on drug concentration (i.e., • L = length (cm), Scr = serum creatinine in mg/dL the same “amount” is eliminated per the more drug in body the more hour regardless of how much drug is in eliminated per hour) • K = age specific proportionality constant: the body – LBW < 1 yr = 0.33, Full term < 1 yr = 0.45, 2‐12 yr 0.55, 13‐21 yr Cp decreases “linearly with time” Cp decreases “exponentially with time” female = 0.55, 13‐21 yr male = 0.70 1half‐life = 50% of original dose gone 2 half‐lives = 75% of original dose gone – Traub Method: CLcr = 0.48 x height (cm)/Scr 3 half‐lives = 87.5% of original dose gone 4 half‐lives = 93.75% of original dose gone • CLcr = creatinine clearance in mL/min/1.73m2, Scr = serum Examples: aspirin, ethanol, phenytoin Examples: gentamicin, vancomycin creatinine in mg/dL Note: Will see a straight line with a graph NOT using logarithmic scale. 19 20 Top Medical Conditions . The Top Medical Conditions in Pediatrics: The Pediatric Patient – Asthma The Top Medical Conditions & – GI complications Medications Prescribed – Allergies – Infectious Problems – Now = Hyperlipidemia 21 22 Top 10 Drugs in Pediatrics Top 10 Drugs in Pediatrics . The 10 Most Commonly Prescribed Medications: . The 10 Most Commonly Prescribed Medications: 1. Amoxicillin 1. Amoxicillin 2. Cefdinir 2. Cefdinir 3. Azithromycin 3. Azithromycin 4. Cipro/Dex Otic 4. Cipro/Dex Otic 5. Albuterol 5. Albuterol 6. Mometasone 6. Mometasone 7. Budesonide 7. Budesonide 8. Cetrizine 8. Cetrizine 9. Montelukast 9. Montelukast 10. Ibuprofen 10. Ibuprofen 23 24 Beta‐Lactams Beta‐Lactams . Mechanism of action take home points: . Bactericidal – Beta‐lactam antibiotics inhibit cell wall synthesis in bacteria . Time dependent killing by inhibiting the enzyme transpeptidase (or also called Beta‐lactam ring penicillin binding protein). This eventual causes lysis of the bacteria and release of intracellular contents – Bacteriocidal – Time dependent killing • We only need to achieve a certain drug concentration and keep it there; more drug is not necessarily better. • This is different that “concentration dependent killing” where more drug or higher concentrations work better. Beta‐lactam ring is subject to attack by beta‐lactamases made from bacteria 25 26 Beta‐Lactams Beta‐Lactams . Aminopenicillins: . Aminopenicillins: – General Uses: • Otitis media, bacterial sinusitis, Lower UTI, Salmonella (amox), Shigella (amp), H. – Are more hydrophilic facilitating passage through porins. pylori, and infective endocarditis prophylaxis in dental procedures (2 g x 1) for – Expanded gr‐ coverage to include H. influenza; E. coli, and high risk patients. – Women’s Health/Pregnancy: PCN and ampicillin are also used for culture Proteus species due to better penetration of outer cell wall of + for group B streptococcus from a vaginal/rectal swab at 35‐37 weeks gr‐ bacteria (via the porins) and greater binding to gestation. transpeptidase, but ring is still open to penicillinase attack • This is done to reduce risk for GBS pneumonia, sepsis, & meningitis. (compare side groups on nafcillin). – DOC in Listeria (meningitis) – ampicillin • Also recommended in empiric treatment of meningococcal meningitis caused by – Good activity against PCN‐resistant pneumococci one of few Neisseria meningitidis which can be life threatening if left untreated (Waterhouse – Friderichsen syndrome). Add to 3rd generation cephalosporin (ceftriaxone). of antibiotics effective against enterococcus. – Memory tool: – Coverage against anaerobes • H: Haemophilus influenza • E: Escherichia coli • L: Listeria monocytogenes • P: Proteus mirabilis • S: Salmonella; Shigella 27 28 Beta‐Lactams Top 10 Drugs in Pediatrics Dosage Drug Usual Dose Misc. Form . The 10 Most Commonly Prescribed Medications: Adjust for renal fx. F=0.4 results 1. Amoxicillin in diarrhea (may cause more 2. Cefdinir C.diff); > absorption if on empty Adults: 250-500 mg q stomach; good for Shigella; not Ampicillin 6hrs 3. Azithromycin PO/IV as good for Salmonella; SE: rash (Principen) Peds: 50-100mg/kg/d (especially if given for 4. Cipro/Dex Otic in 4 divided doses viral/mononucleosis (EBV) viral infection). 5. Albuterol Preg Cat: B; Lact Cat: L1 6. Mometasone Adjust for renal; F = 0.95; good Adults: 250-500 mg for Salmonella; poor for Shigella; 7. Budesonide Amoxicillin q8h SE: rash (especially if given for (Amoxil; PO 8. Cetrizine Peds: 20-50 mg/kg/d in viral/mononucleosis (EBV)

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    15 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us